🇮🇹

Italy for Biotech / Life Sciences

europeWorldwideBIOTECH / LIFE SCIENCES
70
Overall
66
BIOTECH
Industry Rank
#5of 27
Key Strength
Funding
Tax Regime
Worldwide
Verdict
Best For

Founders seeking capital - Italy's funding access (100/100) suits startups that need VC relationships and government co-investment programs.

Not Ideal For

Founders whose top priority is minimising corporate tax - Italy's corporate tax score (32/100) is not a standout advantage.

Bottom Line

Ranked #5 of 27 jurisdictions for Biotech / Life Sciences. Italy's Biotech / Life Sciences score of 66/100 is close to its overall score of 70/100, indicating balanced performance across dimensions.

BIOTECH / LIFE SCIENCES-WEIGHTED DIMENSION PROFILE

Muted: default profile / Blue: industry-weighted

Strengths
Funding100

Strong funding environment for biotech / life sciences operators.

Visa90

Strong visa environment for biotech / life sciences operators.

Family85

Strong family environment for biotech / life sciences operators.

Watch Outs
Tax32

Lower tax score - verify current requirements carefully.

Tax Res.55

Lower tax res. score - verify current requirements carefully.

Remote64

Lower remote score - verify current requirements carefully.

Key Metrics for Biotech / Life Sciences
27.9%
Corporate Tax
80
Active VCs
$1.5B
VC Deployed
Yes
Gov Grants
Yes
EU Funding
65
Talent Pool
Yes
IP Box Regime
30
Incorporation

Why Italy Works for Biotech / Life Sciences

Funding access (100/100) is a standout for Italy Biotech / Life Sciences companies. The local market has 80 active VC funds, with average seed checks of $600K. Government grant programs include Smart & Start Italia (Invitalia) ($1.6M) and EIC Accelerator ($2.7M). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.

Family viability (85/100) is a genuine strength for Italy - important for Biotech / Life Sciences founders relocating with a partner or children. The cost of living index is 55 (NYC = 100), with a comfortable family monthly budget of $4K. Safety scores 65/100. International schools are available, and healthcare quality scores 82/100 with private insurance running approximately $165/month.

Operational ease (83/100) makes Italy practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated moderate. Company formation takes approximately 30 days at a cost of around $3K, with annual compliance costs around $4K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated strong, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.

Watch Outs for Biotech / Life Sciences Founders in Italy

Corporate tax (32/100): Tax efficiency is not the primary reason to choose Italy for Biotech / Life Sciences operations. Founders whose primary goal is minimising the corporate tax line should model effective rates carefully and compare against jurisdictions with zero or near-zero corporate tax.

Personal tax (55/100): Personal income tax tops out at 43%, which is above-average for founder-friendly jurisdictions. The worldwide taxation system means all global income is taxable for residents. Founders planning high personal distributions should model after-tax take-home carefully against lower-tax alternatives.

Remote infrastructure (64/100): Italy presents some limitations for fully remote teams. Connectivity, coworking density, or legal clarity for remote work may require additional planning for distributed Biotech / Life Sciences operations.

Setup Requirements for Biotech / Life Sciences in Italy
  1. Entity type: 100% foreign-owned company permitted - no local partner required
  2. Banking: moderate access for foreign founders. Common options include UniCredit, Intesa Sanpaolo, BNL BNP Paribas.
  3. Formation: approximately 30 days to incorporate, estimated cost $3K plus annual compliance of $4K
  4. Licensing: Regulator - AIFA / EMA pathway
  5. Timeline: 30 days visa processing + 30 days formation = approximately 60 days to be fully operational
  6. Visa pathway: Digital Nomad Visa (minimum income $3K/month, 12-month initial permit)
Industry Key Facts
AIFA / EMA pathway
Regulator
Strong infrastructure, cost-effective
Clinical Trials
210% super-deduction on qualifying R&D
R&D Incentive
Milan, Lombardy Life Sciences
Biotech Cluster
Compare Italy vs Top Alternatives for Biotech / Life Sciences
🇮🇹Italy
66
🇪🇪Estonia
68

Biotech / Life Sciences industry scores

🇮🇹Italy
66
🇸🇬Singapore
73

Biotech / Life Sciences industry scores

Top Biotech / Life Sciences Jurisdictions
Frequently Asked Questions
Is Italy good for Biotech / Life Sciences in 2026?

Italy ranks #5 of 27 jurisdictions for Biotech / Life Sciences on NomadSignal's scoring model, with an industry-weighted score of 66/100. The top strengths for Biotech / Life Sciences founders are funding access and family viability. Whether it is the right choice depends on your funding stage, personal tax situation, and whether you are relocating alone or with a family.

What is the corporate tax rate in Italy?

Italy applies a statutory corporate tax rate of 27.9%, and an IP box regime at N/A for qualifying IP income. The jurisdiction has 100 active tax treaties. For Biotech / Life Sciences founders, corporate tax efficiency carries a 8% weight in the industry scoring model. Verify the current effective rate with a local advisor before making an incorporation decision.

Does Italy have Biotech / Life Sciences-specific programs or incentives?

Italy has strong clinical trial infrastructure and a world-class healthcare system. AIFA (Italian Medicines Agency) works alongside EMA. Hospital networks are extensive and cost-effective for trials. Strong biotech clusters in Milan, Rome, and the Lombardy Life Sciences cluster. 210% R&D super-deduction applies to biotech. Innovative startup status provides additional benefits. Italy offers a startup or entrepreneur visa pathway for qualifying founders. NomadSignal evaluates Biotech / Life Sciences-specific factors including Regulatory Approval Pathway, Clinical Trial Environment, Patent Regime for Biologics as part of the industry score. Check the country's official government and innovation agency websites for current program details.

How does Italy compare to other jurisdictions for Biotech / Life Sciences?

Italy ranks #5 for Biotech / Life Sciences with 66/100. The #1 ranked jurisdiction is Singapore at 73/100. The gap is driven mainly by corporate tax, where Italy is weaker. Use NomadSignal's comparison pages to evaluate Italy head-to-head against specific alternatives.

Discussion (0)

A community of sovereign individuals - founders, families, and remote operators. Share what you know, ask what you don't.

No comments yet - be the first to share what you know about this page.

Data as of March 2026. Not legal, tax, or immigration advice.